Tel: +44 (0)115 974 9000
Fax:

Web: www.quotientsciences.com

Quotient Sciences is a drug development services organization, dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform, which is proven to shorten development timelines and reduce associated costs.

Our worldwide customer base includes leading pharmaceutical and biotechnology companies in Europe, USA and Japan, ranging from large pharma to mid-size biotech.

We employ over 700 staff and operate from state-of- the-art clinical and manufacturing facilities in the U.S. and U.K., including three clinical pharmacology units housing over 400 beds, and 30 GMP manufacturing suites. We work under FDA or MHRA guidelines and offer a full range of support services, from study setup through to data analysis and reporting.

Group Sector

• Adaptive trial design
• CDMO
• CMO
• Data management
• Early phase trials
• FTIH studies
• Patient studies
• Primary and secondary packaging
• Protocol development
• QP services
• Randomisation
• Statistics
• Clinical packaging
• Clinical report writing
• Clinical trial supplies
• Comparator sourcing
• Contract manufacturing
• Drug development services
• Formulation development
• Full service CRO
• Medical writing
• Named patient programs
• Phase I-IV studies
• Product stability testing
• Project management
• QTc studies
• Regulatory
• Statistical programming

Geographical Area

• Europe
• North American
• Far East (incl. Japan, China, South Korea)
• Australia

For further information, please contact:

Robin Bodicoat
Marketing Director
Robin.bodicoat@quotientsciences.com